Evidence for cognitive impairment in mastocytosis: prevalence, features and correlations to depression.
Mastocytosis is a heterogeneous disease characterized by mast cells accumulation in one or more organs. We have reported that depression is frequent in mastocytosis, but although it was already described, little is known about the prevalence and features of cognitive impairment. Our objective was to...
Guardado en:
Autores principales: | Daniela Silva Moura, Serge Sultan, Sophie Georgin-Lavialle, Stéphane Barete, Olivier Lortholary, Raphael Gaillard, Olivier Hermine |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a637eb482ab849c8a44c7ad4f2439e38 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Depression in patients with mastocytosis: prevalence, features and effects of masitinib therapy.
por: Daniela Silva Moura, et al.
Publicado: (2011) -
Clinical potential of midostaurin in advanced systemic mastocytosis
por: Chandesris MO, et al.
Publicado: (2017) -
Case-control cohort study of patients' perceptions of disability in mastocytosis.
por: Olivier Hermine, et al.
Publicado: (2008) -
Phenotypic and genotypic characteristics of mastocytosis according to the age of onset.
por: Fanny Lanternier, et al.
Publicado: (2008) -
Precision Medicine in Systemic Mastocytosis
por: Maura Nicolosi, et al.
Publicado: (2021)